Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Applications of N-acetyl-D-glucosamine in preparing medicines and health products for preventing and treating encephalatrophy and medicines

A technology of glucosamine and brain atrophy, applied in the field of medicine, can solve problems such as ineffective effects and slow effects, achieve or treat brain atrophy, prevent the aggravation of brain atrophy symptoms, and promote metabolism

Inactive Publication Date: 2018-08-24
始祖(吉林)生物波医学研究院集团有限公司
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For brain atrophy, the general treatment methods are drug maintenance, Chinese medicine conditioning, diet regulation, etc. Not only the effect is slow, but the effect is not obvious. At present, there is no method that can completely cure brain atrophy accurately and effectively.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] A capsule prepared by mixing starch and N-acetyl-D-glucosamine and contained in edible capsules. Wherein, the content of N-acetyl-D-glucosamine is 25mg / capsule.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides applications of N-acetyl-D-glucosamine in preparing medicines and health products for preventing and treating encephalatrophy and the medicines, belonging to the field of medicines. For the applications of N-acetyl-D-glucosamine in preparing the medicines for treating encephalatrophy and the applications of N-acetyl-D-glucosamine in preparing the health products aiming at encephalatrophy provided by the invention, the active ingredient, namely, N-acetyl-D-glucosamine can effectively treat or alleviate encephalatrophy, the treatment period is short, and no toxic and sideseffects exist. The active ingredients of the medicines used for treating encephalatrophy comprise N-acetyl-D-glucosamine, which can effectively treat or alleviate encephalatrophy, the treatment period is short, and no toxic and sides effects exist.

Description

technical field [0001] The invention relates to the field of medicine, and in particular to the application and medicine of N-acetyl-D-glucosamine in the preparation of medicines and health care products for preventing and treating brain atrophy. Background technique [0002] Brain atrophy refers to a phenomenon of atrophy caused by organic lesions in the brain tissue itself due to various reasons. Patients often suffer from dizziness and headache, brain atrophy and dreaminess, soreness of waist and knees, numbness of hands and feet, tinnitus and deafness, and gradually become unresponsive, slow in movement, mumbling to themselves, and answering irrelevant questions. In terms of body, it often manifests as aging, white teeth, dry skin, pigmentation, or hemiplegia, epilepsy, ataxia, tremor, etc. Nervous system symptoms may be present or absent. In addition, there will also be memory impairment; changes in personality and behavior; mental decline, in the late stage of the dis...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/7008A61P25/00A23L33/125
CPCA61K31/7008A23L33/125A23V2002/00A61P25/00A23V2200/322A23V2250/61
Inventor 徐启旺姜海林姜则宇
Owner 始祖(吉林)生物波医学研究院集团有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products